Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Change in Accured Expenses (2020 - 2026)

PROCEPT BioRobotics has reported Change in Accured Expenses over the past 7 years, most recently at $180000.0 for Q1 2026.

  • Quarterly Change in Accured Expenses rose 102.74% to $180000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.9 million through Mar 2026, up 96.21% year-over-year, with the annual reading at $142000.0 for FY2025, 96.95% down from the prior year.
  • Change in Accured Expenses was $180000.0 for Q1 2026 at PROCEPT BioRobotics, up from $48000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $8.1 million in Q2 2025 and troughed at -$6.6 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $257000.0 (2022), against an average of $710058.8.
  • Year-over-year, Change in Accured Expenses crashed 885.15% in 2023 and then soared 780.46% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $6.3 million in 2022, then crashed by 95.11% to $307000.0 in 2023, then soared by 780.46% to $2.7 million in 2024, then crashed by 98.22% to $48000.0 in 2025, then skyrocketed by 275.0% to $180000.0 in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Change in Accured Expenses are $180000.0 (Q1 2026), $48000.0 (Q4 2025), and -$1.5 million (Q3 2025).